Novo Nordisk's pricing approaches inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of value gouging, pointing out the stark distinction in between U.S. prices and people in Europe and copyright. Incorporate these bits and pieces i